Copyright
©2013 Baishideng Publishing Group Co.
World J Transplant. Jun 24, 2013; 3(2): 7-25
Published online Jun 24, 2013. doi: 10.5500/wjt.v3.i2.7
Published online Jun 24, 2013. doi: 10.5500/wjt.v3.i2.7
Table 4 Efficacy and effects on biopsy proven and glomerular filtration rate of the main minimization trials
Calcineurin inhibitors | F-up (mo) | Acute rejection | Graft survival | Biopsy proven | Glomerular filtration rate | |
OptiCept | CsA/TAC | 24 | Similar | Similar | Similar | Similar |
CAESAR | CsA | 12 | Similar | Similar | Similar | Similar |
ASSET | TAC | 12 | Similar | Similar | Similar | Similar |
Andres | CsA | 6 | Similar | Similar | Similar | Similar |
2309 | CsA | 12 | Similar | Similar | Similar | Similar |
EVEREST | CsA | 36 | Similar | Similar | Similar | Similar |
REFERENCE Study | CsA | 24 | Similar | Similar | Similar | Similar |
De Sevaux | CsA | 6 | Similar | Similar | Similar | Similar |
- Citation: Salvadori M, Bertoni E. Is it time to give up with calcineurin inhibitors in kidney transplantation? World J Transplant 2013; 3(2): 7-25
- URL: https://www.wjgnet.com/2220-3230/full/v3/i2/7.htm
- DOI: https://dx.doi.org/10.5500/wjt.v3.i2.7